Page last updated: 2024-09-05

olpadronic acid and Brittle Bone Disease

olpadronic acid has been researched along with Brittle Bone Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engelbert, R; Jansen, M; Kok, D; Pruijs, H; Sakkers, R; Schweitzer, D; Uiterwaal, C; van Dongen, A; Verbout, A1
Castelein, RM; Engelbert, RH; Janse, AJ; Kok, DH; Pruijs, HE; Sakkers, RJ; Verbout, AJ1
Landsmeer-Beker, EA; Maaswinkel-Mooy, PD; Massa, GG; Papapoulos, SE; van de Kamp, JJ1

Trials

2 trial(s) available for olpadronic acid and Brittle Bone Disease

ArticleYear
Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study.
    Lancet (London, England), 2004, May-01, Volume: 363, Issue:9419

    Topics: Activities of Daily Living; Administration, Oral; Adolescent; Bone Density; Bone Resorption; Child; Child, Preschool; Diphosphonates; Double-Blind Method; Female; Fractures, Spontaneous; Humans; Locomotion; Male; Osteogenesis Imperfecta

2004
Quality of life in children with osteogenesis imperfecta treated with oral bisphosphonates (Olpadronate): a 2-year randomized placebo-controlled trial.
    European journal of pediatrics, 2007, Volume: 166, Issue:11

    Topics: Achievement; Administration, Oral; Child; Diphosphonates; Double-Blind Method; Humans; Osteogenesis Imperfecta; Psychometrics; Quality of Life; Self Concept; Severity of Illness Index; Sociometric Techniques; Surveys and Questionnaires

2007

Other Studies

1 other study(ies) available for olpadronic acid and Brittle Bone Disease

ArticleYear
Treatment of osteogenesis imperfecta with the bisphosphonate olpadronate (dimethylaminohydroxypropylidene bisphosphonate).
    European journal of pediatrics, 1997, Volume: 156, Issue:10

    Topics: Body Height; Bone Density; Child; Diphosphonates; Follow-Up Studies; Humans; Infant; Long-Term Care; Male; Osteogenesis Imperfecta

1997